@Dr_Keefer Even straight after injection, the measured dose rates at 2MWh distance were only 2-5microSv/hr in this study. https://t.co/sy8lXJcuR9
RT @Monthy_A: External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies https://t.co/OscuoEyyBt
RT @Monthy_A: External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies https://t.co/OscuoEyyBt
External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies https://t.co/OscuoEyyBt
External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies https://t.co/ttYogCqKhZ #177Lu #radioimmunotherapy #biotech #radonc
RT @radiolobt: External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies. - PubMed - NCBI https://t.…
RT @radiolobt: External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies. - PubMed - NCBI https://t.…
RT @radiolobt: External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies. - PubMed - NCBI https://t.…
External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies. - PubMed - NCBI https://t.co/Z78396nMbQ
External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies https://t.co/e794KjOWs9